US 9714270
a4B7 integrin thioether peptide antagonists
granted A61KA61K38/00A61K38/12
Quick answer
US patent 9714270 (a4B7 integrin thioether peptide antagonists) held by Protagonist Therapeutics, Inc. expires Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Protagonist Therapeutics, Inc.
- Grant date
- Tue Jul 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 20 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/00, A61K38/12, A61K47/54, A61K47/545